Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
Clinical trial NCT01392300 · COMPLETED
Trial details
- NCT number
- NCT01392300
- Sponsor
- Merz Pharmaceuticals GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2013-03-01
- Enrollment
- 317
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.